Gates Foundation CEO: FDA's approval of single-dose drug to fight malaria is 'great news'

Sue Desmond-Hellman, Gates Foundation CEO, talks about the importance of a new drug, Krintafel (tafenoquine) that offers hope of a radical cure for malaria. Also Desmond-Hellman shares her thought on preparing for the next pandemic threat.
Fri, Jul 27 20188:07 AM EST